F-star's sale to Chinese buyer cleared by CFIUS following months of holdup

Amber Tong

After taking several months to review F-star’s proposed sale to a Chinese company, the US government’s Committee on Foreign Investment in the United States …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

F-star's sale to Chinese buyer cleared by CFIUS following months of holdup

Amber Tong

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

BridgeBio shares promising results in trial of Canavan disease gene therapy

CRISPR therapy reduces swelling attacks by 81% in Intellia follow-up study

Facing lost rebates, MGM Resorts to stop covering GLP-1 weight loss shots

Exclusive: University of Toronto spinout raises $53.5M to create new obesity drugs with AI

Icon's quarterly earnings hit by biotech and pharma pullback

IDEAYA Biosciences: Targeting unmet market needs with precision oncology

F-star's sale to Chi­nese buy­er cleared by CFIUS fol­low­ing months of holdup

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

F-star's sale to Chinese buyer cleared by CFIUS following months of holdup